Technical Analysis for ONCS - OncoSec Medical Incorporated

Grade Last Price % Change Price Change
grade F 2.09 0.48% 0.01
ONCS closed up 0.48 percent on Friday, January 17, 2020, on 68 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up
Historical ONCS trend table...

Date Alert Name Type % Chg
MACD Bullish Centerline Cross Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Stochastic Reached Overbought Strength 0.00%
Upper Bollinger Band Walk Strength 0.00%
Weak + Overbought Other 0.00%
BB Squeeze Ended Range Expansion 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

OncoSec Medical Incorporated, a hybrid device and gene therapy biotechnology company, designs, develops, and commercializes medical approaches principally immunotherapy for the treatment of solid tumors in the United States. Its clinical programs include three Phase II clinical trials to assess the ImmunoPulse technology in patients with melanoma, Merkel cell carcinoma, and cutaneous T-cell lymphoma. It has a collaboration agreement with Heat Biologics, Inc. to evaluate the combination of immunotherapy platforms. The company was formerly known as NetVentory Solutions Inc. and changed its name to OncoSec Medical Incorporated in March 2011. OncoSec Medical Incorporated is headquartered in San Diego, California.
Medicine Biotechnology Biology Immunotherapy Solid Tumors Cancer Treatments Gene Therapy Virotherapy Melanoma Genetic Engineering Cutaneous T Cell Lymphoma Heat Biologics Merkel Cell Carcinoma

Is ONCS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 9.46
52 Week Low 1.6
Average Volume 85,092
200-Day Moving Average 2.74
50-Day Moving Average 2.00
20-Day Moving Average 1.88
10-Day Moving Average 1.96
Average True Range 0.12
ADX 18.19
+DI 25.57
-DI 12.75
Chandelier Exit (Long, 3 ATRs ) 1.74
Chandelier Exit (Short, 3 ATRs ) 2.06
Upper Bollinger Band 2.08
Lower Bollinger Band 1.69
Percent B (%b) 1.04
BandWidth 20.70
MACD Line 0.01
MACD Signal Line -0.03
MACD Histogram 0.0346
Fundamentals Value
Market Cap 44.24 Million
Num Shares 21.2 Million
EPS -1.14
Price-to-Earnings (P/E) Ratio -1.83
Price-to-Sales 0.00
Price-to-Book 1.51
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.21
Resistance 3 (R3) 2.20 2.15 2.19
Resistance 2 (R2) 2.15 2.12 2.15 2.18
Resistance 1 (R1) 2.12 2.10 2.13 2.13 2.18
Pivot Point 2.07 2.07 2.08 2.08 2.07
Support 1 (S1) 2.04 2.04 2.06 2.05 2.00
Support 2 (S2) 1.99 2.02 2.00 2.00
Support 3 (S3) 1.96 1.99 1.99
Support 4 (S4) 1.97